GlucoTrack (GCTK) elects Victoria Carr-Brendel to Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
May 28, 2025 8:30 AM EDTExperienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology
RUTHERFORD, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced today that Victoria E. Carr-Brendel, PhD, was elected to the Companys Board of Directors, effective May 22, 2025.
We are delighted to welcome Dr. Carr-Brendel to Glucotracks Board of Directors, said Paul V. Goode, PhD, President and Chief... More
